Evaluation of The Therapeutic Role of Coenzyme Q10 and Coconut Oil in Acute Aluminum Phosphide Poisoning Outcomes:A Randomized Controlled Clinical Trial
Phase 2
Recruiting
- Conditions
- Injury, Occupational Diseases, Poisoning
- Registration Number
- PACTR202101703883803
- Lead Sponsor
- Rasha Elhussieny Elsharkawy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 84
Inclusion Criteria
All acute ALP poisoned patients of both sexes admitted to Tanta university poison control center within 6 hours delay after ingestion and fit for gastric lavage will be enrolled in this study.
Exclusion Criteria
•Asymptomatic patients
•Pregnant and lactating women
•Patients with combined drug/chemical ingestion in addition to aluminum phosphide.
•Patients with chronic diseases (e.g. cardiovascular disease, renal or hepatic failure, infection, and cancer).
•Patients with a disturbed consciousness level
•Patients with post-cardiac arrest
patients with ALP inhalation
Patents with previous medical interventions before coming
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method mortality rate
- Secondary Outcome Measures
Name Time Method •Need for intubation and mechanical ventilation.<br>•Need for ICU admission<br>•Duration of hospital stay<br>•Total dose of needed inotropes <br><br>